Zhang [16] et al (2005) in laboratory investigation showed that ASODN (antisense oligonucleotide) can suppress endothelial cell growth and inhibit tumor angiogenesis possibly by specifically blocking VEGF expression in medullary thyroid carcinoma. The gene discussed is VEGFA; the disease is medullary thyroid gland carcinoma.